Skip to main content

Prognostic Significance of Survivin in Pediatric Acute Lymphoblastic Leukemia

Indian Journal of Hematology and Blood Transfusion volume 27, pages 18–25 (2011)Cite this article

Abstract

Impaired apoptosis is mediated by members of the inhibitor of apoptosis proteins (IAP) family such as survivin. Survivin was described in number of different tumors and found to correlate with poor prognosis in a variety of cancers including hematologic malignancies. The aim of this study was to determine survivin in pediatric ALL and compare it with clinical and hematological findings, response to therapy and outcome. Flowcytometry was used for detection of intracellular survivin and determine its mean fluorescence intensity (MFI) in bone marrow mononuclear cells. Patients were followed up for 28 months after induction therapy. Survivin was detected in 63.3% of the patients BM. In spite of no association of survivin levels with established risk factors (P > 0.05) except with high WBC, there was significant higher level of survivin expression in high risk group patients when patients were stratified into high and standard risk groups. According to response to induction therapy, there was no significant difference, in survivin level between patients who achieved CR, RD and ED. However, patients suffering relapse of the disease, had a significant higher basal level of survivin than patients still in remission. Over expression of survivin is a candidate parameter to determine poor prognosis in ALL patients and it may serve to refine treatment stratification with intensification of therapy in those patients prone to relapse.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462

    CAS  Article  PubMed  Google Scholar 

  2. Altieri DC (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3:46–54

    CAS  Article  PubMed  Google Scholar 

  3. Barak Y, Juven T, Haffner R, Oren M (1993) mdm2 expression is induced by wild type p53 activity. EMBO Eur Mol Biol Organ J 12:461–468

    CAS  Google Scholar 

  4. Miyashita T, Krajewski S, Krajewski M et al (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799–1805

    CAS  PubMed  Google Scholar 

  5. Deveraux QL, Reed JC (1999) IPA family proteins: suppressors of apoptosis. Genes Dev 13:239–252

    CAS  Article  PubMed  Google Scholar 

  6. Altieri DC, Marchisio PC, Marchisio PC (1999) Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 79:1327–1333

    CAS  PubMed  Google Scholar 

  7. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921

    CAS  Article  PubMed  Google Scholar 

  8. Swana HS, Grossman D, Anthony JN et al (1999) Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. Lancet 341:452–453

    CAS  Google Scholar 

  9. Yu J, Leung WK, Ebert MPA et al (2002) Increased expression of survivin in gastric cancer patients and in first degree relatives. Br J Cancer 87:91–97

    CAS  Article  PubMed  Google Scholar 

  10. Carter BZ, Milella M, Altieri DC, Andreef M (2001) Cytokine-regulated expression of survivin in myeloid leukemia. Blood 97:2784–2790

    CAS  Article  PubMed  Google Scholar 

  11. Mori A, Wada H, Nishimura Y et al (2002) Expression of the antiapoptosis gene survivin in human leukemia. Int J Hematol 75:161–165

    CAS  Article  PubMed  Google Scholar 

  12. Kawasaki H, Altieri DC, Lu CD et al (1998) Inhibition of apoptosis by surviving predicts shorter survival rates in colorectal cancer. Cancer Res 58:5071–5074

    CAS  PubMed  Google Scholar 

  13. Adida-Adida C, Berrebi D, Paichmaur M et al (1998) Anti-apoptosis gene survivin, and prognosis of neuroblastoma. Lancet 351:882–883

    Article  Google Scholar 

  14. Adida C, Haioun C, Gaulard P et al (2000) Prognostic significance of survivin in diffuse large B-cell lymphomas. Blood 96:1921–1925

    CAS  PubMed  Google Scholar 

  15. Aref S, Salama O, Al-Tonbary Y et al (2004) Assessment of Bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia. Hematology 9(2):113–121

    CAS  Article  PubMed  Google Scholar 

  16. Holleman A, Den Boer ML, Kazemier KM et al (2003) Resistance to different clases of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. Blood 102:4541–4546

    Google Scholar 

  17. Schimmer AD, Hedley DW, Penn LZ et al (2003) Receptor and mitochondrial-mediated apoptosis in acute leukemia: a translational view. Blood 98:3541–3553

    Article  Google Scholar 

  18. Tamm I, Wang Y, Sausville E et al (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315–5320

    CAS  PubMed  Google Scholar 

  19. Harms DO, Janka-Schaub GE et al (2000) Cooperative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92. Leukemia 14:2234–2239

    CAS  Article  PubMed  Google Scholar 

  20. Troeger A, Siepermann M, Escherich G et al (2007) Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia. Haematologica 92:1043–1050

    CAS  Article  PubMed  Google Scholar 

  21. Rubnitz JE. Acute lymphoblastic Leukemia. http://www.emedicine.com/med/topic2587.htm. Accessed 7 Nov 2009

  22. Seabright M (1971) A rapid banding technique for human chromosomes. Lancet 30:971

    Article  Google Scholar 

  23. Schmid I, Uittenbogaart CH, Giorgi JV (1991) A gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification. Cytometry 12(3):274–285

    Article  Google Scholar 

  24. Paydas S, Tanriverdi K, Yavuz S et al (2003) survivin and aven: two distinct antiapoptotic signals in acute leukemias. Ann Oncol 14:1045–1050

    CAS  Article  PubMed  Google Scholar 

  25. Li F, Ambrosini G, Chu EY et al (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580–584

    CAS  Article  PubMed  Google Scholar 

  26. Holleman A, den Boer ML, de Menezes RX et al (2006) The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood 107:769–776

    CAS  Article  PubMed  Google Scholar 

  27. Hayashibara T, Yamada Y, Nakayama S et al (2002) Resveratrol induces down regulation in surviving expression and apoptosis in HTLV- 1-infected cell lines: a prospective agent for adult T cell leukemia chemotherapy. Nutr Cancer 44:193–201

    Article  PubMed  Google Scholar 

  28. Carter BZ, Wang RY, Schober WD et al (2003) Targeting survivin expression induces cell proliferation defect and subsequent cell death involving mitochondrial pathway in myeloid leukemic cells. Cell Cycle 2:488–493

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Clinical Pathology, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Asmaa M. Esh, Maha Atfy, Nashwa A. Azizi, Mohamed M. El Naggar & Ebtesam E. Khalil

  2. Department of Pediatric, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Layla Sherief

Authors
  1. Asmaa M. Esh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maha Atfy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nashwa A. Azizi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mohamed M. El Naggar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ebtesam E. Khalil
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Layla Sherief
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maha Atfy.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Esh, A.M., Atfy, M., Azizi, N.A. et al. Prognostic Significance of Survivin in Pediatric Acute Lymphoblastic Leukemia. Indian J Hematol Blood Transfus 27, 18–25 (2011). https://doi.org/10.1007/s12288-010-0053-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-010-0053-z

Keywords

  • Pediatric ALL
  • Survivin
  • Prognosis